What Is Strategies For Engineered Negligible Senescence
SENS is an acronym that stands for “strategies for engineered negligible senescence,” and it refers to a group of regenerative medical treatments that are either planned or already in development with the goal of repairing all age-related damage to human tissue on a periodic basis. These treatments are being developed with the ultimate goal of keeping patients in a condition of minimal senescence and delaying the onset of age-related diseases. Aubrey de Grey, a British biogerontologist, was the one who initially coined the term SENS.
How You Will Benefit
(I) Insights, and validations about the following topics:
Chapter 1: Strategies for engineered negligible senescence
Chapter 2: Life extension
Chapter 3: Gerontology
Chapter 4: Aubrey de Grey
Chapter 5: Biogerontology
Chapter 6: Rejuvenation
Chapter 7: Index of topics related to life extension
Chapter 8: Rejuvenation Research
Chapter 9: Outline of life extension
Chapter 10: Preston Estep
Chapter 11: Suresh Rattan
Chapter 12: Aging-associated diseases
Chapter 13: Longevity escape velocity
Chapter 14: Methuselah Foundation
Chapter 15: Ending Aging
Chapter 16: Pro-aging trance
Chapter 17: SENS Research Foundation
Chapter 18: Anti-aging movement
Chapter 19: Senolytic
Chapter 20: Societal effects of negligible senescence
Chapter 21: Timeline of senescence research
(II) Answering the public top questions about strategies for engineered negligible senescence.
(III) Real world examples for the usage of strategies for engineered negligible senescence in many fields.
(IV) 17 appendices to explain, briefly, 266 emerging technologies in each industry to have 360-degree full understanding of strategies for engineered negligible senescence' technologies.
Who This Book Is For
Professionals, undergraduate and graduate students, enthusiasts, hobbyists, and those who want to go beyond basic knowledge or information for any kind of strategies for engineered negligible senescence.
